MannKind (MNKD) News Today → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free MNKD Stock Alerts $4.18 -0.01 (-0.24%) (As of 03:52 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMannKind (NASDAQ:MNKD) Share Price Crosses Above 200 Day Moving Average of $3.90americanbankingnews.com - April 16 at 2:34 AMMannKind (NASDAQ:MNKD) Shares Up 4.9%marketbeat.com - April 5 at 2:18 PMMannKind Repays Certain Debt Obligationsglobenewswire.com - April 3 at 6:00 AMMannKind Corporation (NASDAQ:MNKD) down to US$1.2b market cap, but institutional owners may not be as affected after a year of 9.7% returnsfinance.yahoo.com - April 1 at 4:37 PMMay 10th Options Now Available For MannKind (MNKD)nasdaq.com - March 30 at 12:57 PMMannKind CFO Steven Binder to retire, Chris Prentiss to take overuk.investing.com - March 28 at 9:06 PMMannKind (NASDAQ:MNKD) Trading Down 3.9%marketbeat.com - March 27 at 12:45 PMMannKind Announces CFO Transitionglobenewswire.com - March 26 at 4:05 PMJim Cramer Says You Should Avoid These 11 Stocksfinance.yahoo.com - March 25 at 12:57 PMMannKind (NASDAQ:MNKD) Shares Up 3.6%marketbeat.com - March 22 at 5:05 PMMannKind (NASDAQ:MNKD) Receives "Overweight" Rating from Cantor Fitzgeraldmarketbeat.com - March 18 at 6:34 PMMNKD Mar 2024 5.000 putfinance.yahoo.com - March 17 at 8:28 PMMNKD Mar 2024 4.000 callfinance.yahoo.com - March 16 at 8:51 AMMNKD Mar 2024 4.500 putfinance.yahoo.com - March 16 at 8:51 AMWhat's Going On With MannKind Stock?msn.com - March 11 at 2:32 PMMannKind (NASDAQ:MNKD) Shares Down 4.9% marketbeat.com - March 11 at 11:52 AMINHALE-3 Study’s Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumpsfinance.yahoo.com - March 11 at 9:31 AMINHALE-3 Study's Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumpsglobenewswire.com - March 11 at 6:05 AMMNKD Mar 2024 6.500 callfinance.yahoo.com - March 10 at 1:57 PMMNKD Mar 2024 3.000 putfinance.yahoo.com - March 9 at 9:03 AMMNKD Mar 2024 3.500 putfinance.yahoo.com - March 8 at 10:17 PMMannKind Announces New Clinical Data From Inhale-3 Study to be Presented by Dr. Irl B. Hirsch at ATTD on March 8globenewswire.com - March 5 at 6:05 AMMannKind Corporation Announces Participation at Upcoming Conferencesglobenewswire.com - March 4 at 1:01 PMMNKD Mar 2024 7.000 callca.finance.yahoo.com - March 3 at 6:39 PMAnalysts Just Made A Meaningful Upgrade To Their MannKind Corporation (NASDAQ:MNKD) Forecastsfinance.yahoo.com - March 3 at 8:38 AM300,000 Shares in MannKind Co. (NASDAQ:MNKD) Purchased by Oracle Investment Management Inc.marketbeat.com - March 1 at 11:48 AMQ1 2024 EPS Estimates for MannKind Co. Raised by Leerink Partnrs (NASDAQ:MNKD)marketbeat.com - March 1 at 7:25 AMMannKind Full Year 2023 Earnings: Beats Expectationsfinance.yahoo.com - February 29 at 9:39 AMQ3 2024 EPS Estimates for MannKind Co. Reduced by Analyst (NASDAQ:MNKD)marketbeat.com - February 29 at 8:38 AMMannKind Corporation (MNKD) stock price, news, quote & history – Yahoo Financeuk.finance.yahoo.com - February 29 at 12:37 AMMannKind Corporation: Strong Growth and Clinical Advancements Prompt Buy Ratingmarkets.businessinsider.com - February 28 at 2:36 PMMannKind Corporation (NASDAQ:MNKD) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - February 28 at 2:36 PMQ4 2023 MannKind Corp Earnings Callfinance.yahoo.com - February 28 at 9:36 AMMannKind Co. (NASDAQ:MNKD) Shares Bought by Connor Clark & Lunn Investment Management Ltd.marketbeat.com - February 28 at 7:17 AMMannKind Corp (MNKD) Reports Substantial Revenue Growth in 2023finance.yahoo.com - February 27 at 6:01 PMMannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development Updateglobenewswire.com - February 27 at 4:00 PMMannKind Stock (NASDAQ:MNKD) Insider Tradesbenzinga.com - February 22 at 5:07 PMMannKind (MNKD) Set to Announce Quarterly Earnings on Tuesdaymarketbeat.com - February 21 at 8:58 AMRafferty Asset Management LLC Has $3.53 Million Position in MannKind Co. (NASDAQ:MNKD)marketbeat.com - February 21 at 6:42 AMMannKind Corporation to Hold 2023 Fourth Quarter and Full Year Financial Results Conference Call on February 27, 2024finance.yahoo.com - February 20 at 8:37 AMMannKind Corporation to Hold 2023 Fourth Quarter and Full Year Financial Results Conference Call on February 27, 2024globenewswire.com - February 20 at 6:00 AMMNKD Feb 2024 4.000 callfinance.yahoo.com - February 16 at 7:20 PMMannKind Co. (NASDAQ:MNKD) Stock Holdings Lowered by Barclays PLCmarketbeat.com - February 16 at 4:32 AMMannKind Announces Enrollment Goal Completion of INHALE-1 Pediatric Diabetes Trial Utilizing Afrezzafinanznachrichten.de - February 15 at 12:19 PMMannKind Announces Enrollment Goal Completion of INHALE-1 Pediatric Diabetes Trial Utilizing Afrezza®finance.yahoo.com - February 15 at 7:19 AMMannKind Announces Enrollment Goal Completion of INHALE-1 Pediatric Diabetes Trial Utilizing Afrezza®globenewswire.com - February 15 at 6:05 AMMannKind's Tyvaso DPI Royalty Deal Signals Undervaluationseekingalpha.com - February 14 at 9:16 PMMNKD Feb 2024 2.000 callfinance.yahoo.com - February 13 at 2:45 AMLeerink Partnrs Comments on MannKind Co.'s Q1 2024 Earnings (NASDAQ:MNKD)marketbeat.com - February 7 at 8:06 AMMannKind (NASDAQ:MNKD) Hits New 12-Month Low at $3.17marketbeat.com - February 5 at 11:33 AM Get MannKind News Delivered to You Automatically Sign up to receive the latest news and ratings for MNKD and its competitors with MarketBeat's FREE daily newsletter. Email Address Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide MNKD Media Mentions By Week MNKD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MNKD News Sentiment▼0.000.42▲Average Medical News Sentiment MNKD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MNKD Articles This Week▼03▲MNKD Articles Average Week Get MannKind News Delivered to You Automatically Sign up to receive the latest news and ratings for MNKD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Ironwood Pharmaceuticals News Innoviva News OPKO Health News Ligand Pharmaceuticals News Dynavax Technologies News AnaptysBio News Phibro Animal Health News Radius Recycling News Lexicon Pharmaceuticals News XOMA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MNKD) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MannKind Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
